Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASBP | AZN | AMGN | GILD | BMY |
| Company | Aspire Biopharma Holdings Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 5.01 | 183.36 | 332.32 | 133.55 | 55.90 |
| High | 5.14 | 186.37 | 338.00 | 135.07 | 56.83 |
| Low | 5.01 | 183.33 | 330.06 | 131.88 | 55.85 |
| Latest | 5.15 | 185.72 | 332.96 | 133.08 | 56.42 |
| Change | -0.02 | +1.18 | -3.33 | -1.86 | -0.03 |
| % Change | -0.39% | +0.64% | -0.99% | -1.38% | -0.05% |
| Volume | 55,905 | 642,225 | 551,124 | 2,245,713 | 1,554,870 |
| 20-Day Average Volume | 1,353,341 | 2,021,795 | 2,605,802 | 5,973,747 | 9,878,038 |
| Previous Close | 5.17 | 184.54 | 336.29 | 134.94 | 56.45 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.39 | 188.83 | 338.83 | 132.99 | 57.90 |
| 20-Day Raw Stochastic | 12.60% | 20.24% | 33.48% | 41.50% | 11.26% |
| 20-Day Relative Strength | 32.94 | 43.36 | 43.39 | 45.54 | 42.97 |
| Weighted Alpha | -90.89 | +27.67 | +17.10 | +24.10 | +19.08 |
| Today's Opinion | 100% Sell | 8% Sell | 24% Sell | 8% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 8% Sell | 8% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 56% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.32% since 05/06/26 | +0.11% since 05/06/26 | +0.48% since 05/06/26 | -2.51% since 05/06/26 | -1.02% since 05/06/26 |
| Low | 3.31 on 05/08/26 | 181.03 on 05/07/26 | 327.22 on 05/07/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 7.05 on 05/07/26 | 186.28 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.02 on 05/12/26 |
| 1-Month | |||||
| %Chg | -85.20% since 04/13/26 | -8.47% since 04/13/26 | -4.89% since 04/13/26 | -4.42% since 04/13/26 | -3.53% since 04/13/26 |
| Low | 3.31 on 05/08/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 36.30 on 04/14/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -88.21% since 02/13/26 | -9.94% since 02/13/26 | -9.88% since 02/13/26 | -14.26% since 02/13/26 | -7.79% since 02/13/26 |
| Low | 3.31 on 05/08/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 48.90 on 02/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -95.99% since 11/13/25 | +4.46% since 11/13/25 | -0.98% since 11/13/25 | +6.13% since 11/13/25 | +15.18% since 11/13/25 |
| Low | 3.31 on 05/08/26 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 205.20 on 01/07/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 865 | 286,204,544 | 181,490,688 | 167,537,456 | 115,274,912 |
| Shares Outstanding, K | 167 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 10,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -24,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -4,710,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.21 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.60 on 11/14/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/13/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.64 | 14.91 | 15.95 | 9.39 |